Patient and Clinician: Mutual Shareholders in the Treatment of Chronic Pain
Release Date: August 01, 2007
Expiration Date: August 01, 2010
Optimal management of chronic pain requires the use of clear communication skills on the part of both patient and clinician. The standard or traditional model of health care communications is biogenic, also called disease centered, with the clinician as primary decision maker. Emerging research has demonstrated that management of chronic pain can be improved through integration of a patient-centered, self-management model of communications and care, placing the patient, not the disease or clinician, at center of communications, care, decision making and treatment. The primary objective of this monograph is to increase awareness surrounding the improved model of patient-clinician communications related to effective pain control and to discuss applications of strategies used to promote optimal communication between patients, health care providers, family members/caregivers and patient advocates.
This activity is designed for physicians, pharmacists, physician assistants, and nurses who have an interest in enhancing their knowledge and understanding of pain management.
Upon completion of this activity, participants should be able to:
- Compare and contrast the disease-centered model of care with the patient-centered model of care.
- Describe three educational resources that may be recommended to patients to assist with the process of their informed consent.
- Compare and contrast the traditional model of decision making with the model of shared decision making.
- Identify the five descriptors related to the SMART tool used in patient goal setting.
- Cite two examples of therapeutic and economic benefits related to patient self-management.
This activity is eligible for credit through August 1, 2010. After this date, this activity will expire and no further credit will be awarded.
There are no fees for participating in this activity. All participants must complete the Activity Evaluation Form. Participants must receive a minimum score of 70% on the self-assessment portion of the form to qualify for CE credit. Certificates may be printed immediately after completing the online self-assessment and evaluation.
Dr. April Hazard Vallerand received her bachelor's degree in nursing from Mount St. Mary's College in Los Angeles, and her master of science degree in nursing from California State University, Los Angeles. She received her doctorate degree in nursing from the University of Pennsylvania, in Philadelphia, and completed a three-year postdoctoral fellowship in psychosocial oncology at the University of Pennsylvania, School of Nursing. Dr. Vallerand is currently an associate professor at the College of Nursing, Wayne State University in Detroit, Michigan and a fellow in the American Academy of Nursing. Her research includes improvement and maintenance of functional status in, and prevention of disparities in care of chronic pain patients. She was a panel member of the American Pain Society for the development of Guidelines for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis and the American Geriatric Society for the development of guidelines for the Management of Persistent Pain in Older Persons. Dr. Vallerand lectures nationally and has published numerous articles on pain and pain management.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of MediCom Worldwide, Inc. and Medical Learning Solutions. MediCom Worldwide, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour(s) of Continuing Education Credit. Universal Activity Number: 827-999-07-088-H01-P Knowledge-based CPE activity.
Accreditation Statement: This activity has been planned and implemented through the joint sponsorship of MediCom Worldwide, Inc. and Medical Learning Solutions. MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 07-188-183
It is the policy of MediCom Worldwide, Inc. to plan and implement educational activities in accordance with the ACCME, ACPE and California Board of Nursing. As a provider, it is the policy of MediCom Worldwide, Inc. to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All program planners, faculty, and providers are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity.
Faculty Financial Disclosure
The presenting faculty reported the following: Dr. April Vallerand has disclosed that she has no significant relationships with the grantor Cephalon, Inc. or any other commercial company whose products and services may be related to her presentation.
Planner and Provider Financial Disclosure
The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, executive director and Alan Vogenberg, RPh, FASCP, clinical advisor have nothing to disclose.
Jeffrey Gudin, MD was the clinical reviewer for this activity and has nothing to disclose. Ruth Widmer, medical writer of Corona Productions has nothing to disclose.
Conflict of Interest Resolution
To identify and resolve conflicts of interest the educational content was fully peer reviewed by a member of the MediCom Worldwide, Inc. Clinical Content Review Committee who has nothing to disclose. The resulting activity was found to provide educational content that is current, evidence based, and commercially balanced.
In accordance with MediCom Worldwide, Inc. policy, the audience is advised of the following disclosures regarding unlabeled or unapproved uses of drugs or devices:
At the time of printing, Dr. Vallerand indicated that her presentation would not include the discussion of unlabeled uses of commercial products or investigational products not yet approved by the FDA for any use in the United States.
MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player or Microsoft®Silverlight™.
This activity is supported by an independent educational grant from
©2007 MediCom Worldwide, Inc. 101 Washington St., Morrisville, PA 19067. No portion of this material may be copied or duplicated without the expressed permission of MediCom.